Supraselective intra-arterial chemotherapy: Evaluation of treatment-related complications in advanced retinoblastoma

Clinical Ophthalmology

Volumn 5, Issue 1, 2011, Pages 171-176

  Vajzovic, Lejla Mutapcic ^a   Murray, Timothy G ^a   Aziz Sultan, Mohammad A ^b   Schefler, Amy C ^a   Wolfe, Stacey Quintero ^b   Hess, Ditte ^a   Fernandes, Cristina E ^b   Dubovy, Sander R ^a,c  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c Florida Lions Oculopathology Laboratory   (United States)

Author keywords

Intra arterial chemotherapy; Melphalan; Retinoblastoma

Indexed keywords

MELPHALAN;

ADVANCED CANCER; ADVERSE OUTCOME; ARTERY CATHETERIZATION; ARTICLE; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CHILD; CHOROID DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG INFUSION; DRUG SAFETY; DRUG TREATMENT FAILURE; ECHOGRAPHY; ENUCLEATION; EYE EDEMA; EYE PHOTOGRAPHY; EYE SWELLING; FOLLOW UP; HEMATOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFANT; INJECTION SITE BLEEDING; LASER COAGULATION; LASER SURGERY; MICROEMBOLISM; MYOSITIS; NEUTROPENIA; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PRESCHOOL CHILD; RETINA BLOOD VESSEL OCCLUSION; RETINA DISEASE; RETINA HEMORRHAGE; RETINOBLASTOMA; RETINOPATHY; SCHOOL CHILD; SCROTUM DISORDER; SYSTEMIC DISEASE; TUMOR REGRESSION; VITREOUS BODY; VITREOUS HEMORRHAGE;

EID: 79952825179     PISSN: 11775467     EISSN: 11775483     Source Type: Journal    
DOI: 10.2147/OPTH.S12665     Document Type: Article

References (18)

1. Abramson DH. Retinoblastoma incidence in the United States. Arch Ophthalmol. 1990;108(11):1514.
2. Tamboli A, Podgor MJ, Horm JW. The incidence of retinoblastoma in the United States: 1974 through 1985. Arch Ophthalmol. 1990; 108:128-132.
3. Cassady JR, Sagerman RH, Tretter P, Ellsworth RM. Radiation therapy in retinoblastoma. An analysis of 230 cases. Radiology. 1969;93: 405-409.
4. Desjardins L, Haye C, Schlienger P, Laurent M, Zucker JM, Bouguila H. Second non-ocular tumours in survivors of bilateral retinoblastoma. A 30-year follow-up. Ophthalmic Paediatr Genet. 1991;12(3): 145-148.
5. Marees T, Moll AC, Imhof SM, de Boer MR, Ringens PJ, van Leeuwen FE. Risk of second malignancies in survivors of retinoblastoma: more than 40 years of follow-up. J Natl Cancer Inst. 2008; 100(24):1743-1745.
6. Shields JA, Shields CL, Meadows AT. Chemoreduction in the management of retinoblastoma. Am J Ophthalmol. 2005;140(3): 505-506.
7. Benz MS, Scott IU, Murray TG, Kramer D, Toledano S. Complications of systemic chemotherapy as treatment of retinoblastoma. Arch Ophthalmol. 2000;118:577-578.
8. Abramson DH. Retinoblastoma in the 20th century: past success and future challenges the Weisenfeld lecture. Invest Ophthalmol Vis Sci. 2005;46(8):2683-2691.
9. Abramson DH, Schefler AC. Update on retinoblastoma. Retina. 2004; 24:828-848.
10. Mulvihill A, Budning A, Jay V, et al. Ocular motility changes after sub-tenon carboplatin chemotherapy for retinoblastoma. Arch Ophthalmol. 2003;121:1120-1124.
11. Kiratli H, Kocabeyoglu S, Bilgic S. Severe pseudo-preseptal cellulites following sub-tenon's carboplatin injection for intraocular retinoblastoma. J AAPOS. 2007;11(4):404-405.
12. Schmack I, Hubbard GB, Kang SJ, Aaberg TM Jr, Grossniklaus HE. Ischemic necrosis and atrophy of the optic nerve after periocular carboplatin injection for intraocular retinoblastoma. Am J Ophthalmol. 2006;142(2):310-315.
13. Yamane T, Kaneko A, Mohri M. The technique of ophthalmic arterial infusion therapy for patients with intraocular retinoblastoma. Int J Clin Oncol. 2004;9(2):69-73.
14. Abramson DH, Dunkel IJ, Brodie SE, Kim JW, Gobin YP. A phase I/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma initial results. Ophthalmology. 2008;115:1398-1404,1404.e1391.
15. Vajzovic LM, Murray TG, Aziz-Sultan MA, et al. Clinicopathologic review of enucleated eyes after intra-arterial chemotherapy with melphalan for advanced retinoblastoma. Arch Ophthalmol. 2010; 128(12):1619-1623.
16. Aziz HA, Boutrid H, Murray TG, et al. Supraselective injection of intraarterial melphalan as the primary treatment for late presentation unilateral multifocal stage Vb retinoblastoma. Retina. 2010; 30 Suppl 4:S63-S65.
17. Boutrid H, Wolfe SQ, Murray TG, et al. Bilateral orbital vasculature alterations after systemic chemotherapy and external beam radiation therapy treatment of advanced retinoblastoma: implications for intra arterial chemotherapy management. Retin Cases Brief Rep. 2010 Jan 15.
18. Brodie SE, Pierre Gobin Y, Dunkel IJ, Kim JW, Abramson DH. Persistence of retinal function after selective ophthalmic artery chemotherapy infusion for retinoblastoma. Doc Ophthalmol. 2009; 119(1):13-22.